

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 6.74555606 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.74555606 |
| 3 | negative regulation of inclusion body assembly (GO:0090084) | 5.10889841 |
| 4 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.97008245 |
| 5 | ensheathment of neurons (GO:0007272) | 4.87014124 |
| 6 | axon ensheathment (GO:0008366) | 4.87014124 |
| 7 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.80285298 |
| 8 | myelination (GO:0042552) | 4.76782624 |
| 9 | regulation of extracellular matrix disassembly (GO:0010715) | 4.72639930 |
| 10 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.39642318 |
| 11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.29004280 |
| 12 | glycine transport (GO:0015816) | 4.25975849 |
| 13 | myelin maintenance (GO:0043217) | 4.25591370 |
| 14 | ER overload response (GO:0006983) | 4.24416186 |
| 15 | positive T cell selection (GO:0043368) | 4.03329274 |
| 16 | creatine metabolic process (GO:0006600) | 4.02892977 |
| 17 | fatty acid elongation (GO:0030497) | 3.96410274 |
| 18 | negative T cell selection (GO:0043383) | 3.93616652 |
| 19 | photoreceptor cell differentiation (GO:0046530) | 3.90330781 |
| 20 | eye photoreceptor cell differentiation (GO:0001754) | 3.90330781 |
| 21 | response to lipoprotein particle (GO:0055094) | 3.88563775 |
| 22 | regulation of T-helper cell differentiation (GO:0045622) | 3.87517666 |
| 23 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.85574828 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.83680559 |
| 25 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.80875100 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.77478773 |
| 27 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.70466928 |
| 28 | ear development (GO:0043583) | 3.67631518 |
| 29 | tolerance induction (GO:0002507) | 3.61026416 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.59614970 |
| 31 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.57394394 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.48218013 |
| 33 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.45631220 |
| 34 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.43488212 |
| 35 | negative thymic T cell selection (GO:0045060) | 3.43395869 |
| 36 | Rap protein signal transduction (GO:0032486) | 3.40493930 |
| 37 | asymmetric protein localization (GO:0008105) | 3.35832754 |
| 38 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.35800150 |
| 39 | T cell selection (GO:0045058) | 3.35577349 |
| 40 | thymic T cell selection (GO:0045061) | 3.35000370 |
| 41 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.34976651 |
| 42 | * oligodendrocyte differentiation (GO:0048709) | 3.34245575 |
| 43 | * negative regulation of JUN kinase activity (GO:0043508) | 3.33732744 |
| 44 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.31829160 |
| 45 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.31829160 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31762550 |
| 47 | positive regulation of defense response to virus by host (GO:0002230) | 3.29889264 |
| 48 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.29708899 |
| 49 | positive regulation of mRNA catabolic process (GO:0061014) | 3.29229307 |
| 50 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.29014591 |
| 51 | regulation of germinal center formation (GO:0002634) | 3.28874385 |
| 52 | protein K11-linked deubiquitination (GO:0035871) | 3.27357043 |
| 53 | T cell receptor signaling pathway (GO:0050852) | 3.24198883 |
| 54 | regulation of B cell apoptotic process (GO:0002902) | 3.23918016 |
| 55 | cytidine metabolic process (GO:0046087) | 3.21200789 |
| 56 | cytidine catabolic process (GO:0006216) | 3.21200789 |
| 57 | cytidine deamination (GO:0009972) | 3.21200789 |
| 58 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.19539301 |
| 59 | regulation of T cell tolerance induction (GO:0002664) | 3.17887267 |
| 60 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.17224893 |
| 61 | regulation of interferon-alpha production (GO:0032647) | 3.16811713 |
| 62 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.14480973 |
| 63 | T-helper cell differentiation (GO:0042093) | 3.14480973 |
| 64 | radial glial cell differentiation (GO:0060019) | 3.13844661 |
| 65 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.12797624 |
| 66 | membrane raft organization (GO:0031579) | 3.12627081 |
| 67 | negative regulation of B cell activation (GO:0050869) | 3.12164268 |
| 68 | regulation of chronic inflammatory response (GO:0002676) | 3.10155173 |
| 69 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.09901732 |
| 70 | activated T cell proliferation (GO:0050798) | 3.09281975 |
| 71 | negative regulation of B cell proliferation (GO:0030889) | 3.07562844 |
| 72 | positive regulation of glial cell differentiation (GO:0045687) | 3.07275450 |
| 73 | immunoglobulin mediated immune response (GO:0016064) | 3.03979759 |
| 74 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.03575828 |
| 75 | interferon-gamma production (GO:0032609) | 3.03504817 |
| 76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.02679585 |
| 77 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.00906027 |
| 78 | response to peptidoglycan (GO:0032494) | 3.00169634 |
| 79 | positive regulation of protein homooligomerization (GO:0032464) | 2.99423451 |
| 80 | positive regulation of interleukin-12 production (GO:0032735) | 2.98376921 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 2.97154906 |
| 82 | NIK/NF-kappaB signaling (GO:0038061) | 2.95758027 |
| 83 | gland morphogenesis (GO:0022612) | 2.94357182 |
| 84 | positive regulation of cell fate commitment (GO:0010455) | 2.94159238 |
| 85 | apical protein localization (GO:0045176) | 2.90716791 |
| 86 | regulation of B cell differentiation (GO:0045577) | 2.90008831 |
| 87 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.87249837 |
| 88 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.86496897 |
| 89 | positive regulation of interleukin-2 production (GO:0032743) | 2.85827368 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84452035 |
| 91 | histamine secretion (GO:0001821) | 2.84075732 |
| 92 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83617807 |
| 93 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.82228060 |
| 94 | establishment of mitochondrion localization (GO:0051654) | 2.81281306 |
| 95 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80686967 |
| 96 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.80469614 |
| 97 | T cell differentiation involved in immune response (GO:0002292) | 2.80469614 |
| 98 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.80469614 |
| 99 | response to redox state (GO:0051775) | 2.80382879 |
| 100 | COPI coating of Golgi vesicle (GO:0048205) | 2.78919342 |
| 101 | Golgi transport vesicle coating (GO:0048200) | 2.78919342 |
| 102 | peripheral nervous system axon ensheathment (GO:0032292) | 2.78538287 |
| 103 | myelination in peripheral nervous system (GO:0022011) | 2.78538287 |
| 104 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.78130179 |
| 105 | cellular response to interleukin-15 (GO:0071350) | 2.77975546 |
| 106 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.77708018 |
| 107 | heterotypic cell-cell adhesion (GO:0034113) | 2.77493454 |
| 108 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.76928804 |
| 109 | peripheral nervous system development (GO:0007422) | 2.76734819 |
| 110 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.75380457 |
| 111 | T cell costimulation (GO:0031295) | 2.74668662 |
| 112 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.74522810 |
| 113 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.74448659 |
| 114 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74090469 |
| 115 | artery smooth muscle contraction (GO:0014824) | 2.74008871 |
| 116 | negative regulation of bone resorption (GO:0045779) | 2.73152483 |
| 117 | positive regulation of interferon-beta production (GO:0032728) | 2.72638777 |
| 118 | activation of MAPKKK activity (GO:0000185) | 2.72607882 |
| 119 | lymphocyte costimulation (GO:0031294) | 2.72406060 |
| 120 | positive regulation of natural killer cell activation (GO:0032816) | 2.71967226 |
| 121 | protein K63-linked deubiquitination (GO:0070536) | 2.71571141 |
| 122 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.71391492 |
| 123 | B cell mediated immunity (GO:0019724) | 2.70714938 |
| 124 | astrocyte differentiation (GO:0048708) | 2.70192907 |
| 125 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.69768915 |
| 126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.68619697 |
| 127 | response to protozoan (GO:0001562) | 2.68299982 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.68171734 |
| 129 | positive regulation of tolerance induction (GO:0002645) | 2.68048036 |
| 130 | regulation of T-helper 1 type immune response (GO:0002825) | 2.67965408 |
| 131 | regulation of defense response to virus by host (GO:0050691) | 2.66108223 |
| 132 | B cell homeostasis (GO:0001782) | 2.65792672 |
| 133 | regulation of translation in response to stress (GO:0043555) | 2.65561570 |
| 134 | positive regulation of autophagy (GO:0010508) | 2.65428063 |
| 135 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.64857029 |
| 136 | regulation of interleukin-12 production (GO:0032655) | 2.64727357 |
| 137 | negative regulation of B cell apoptotic process (GO:0002903) | 2.64425921 |
| 138 | mature B cell differentiation involved in immune response (GO:0002313) | 2.64353516 |
| 139 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.62297294 |
| 140 | protein palmitoylation (GO:0018345) | 2.62229914 |
| 141 | membrane protein ectodomain proteolysis (GO:0006509) | 2.61797710 |
| 142 | regulation of fibroblast apoptotic process (GO:2000269) | 2.61475715 |
| 143 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61394970 |
| 144 | negative regulation of neurotransmitter transport (GO:0051589) | 2.61209086 |
| 145 | regulation of B cell proliferation (GO:0030888) | 2.60880641 |
| 146 | virion attachment to host cell (GO:0019062) | 2.60723533 |
| 147 | adhesion of symbiont to host cell (GO:0044650) | 2.60723533 |
| 148 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.60214644 |
| 149 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.60189075 |
| 150 | defense response to protozoan (GO:0042832) | 2.60160718 |
| 151 | regulation of mRNA catabolic process (GO:0061013) | 2.60144658 |
| 152 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.59795104 |
| 153 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.59314390 |
| 154 | piRNA metabolic process (GO:0034587) | 2.59207189 |
| 155 | * glial cell differentiation (GO:0010001) | 2.58387015 |
| 156 | cellular response to arsenic-containing substance (GO:0071243) | 2.58212931 |
| 157 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.57588694 |
| 158 | response to interleukin-15 (GO:0070672) | 2.54960028 |
| 159 | endocrine pancreas development (GO:0031018) | 2.54551790 |
| 160 | positive regulation of DNA recombination (GO:0045911) | 2.53484948 |
| 161 | cellular response to type I interferon (GO:0071357) | 2.53344009 |
| 162 | type I interferon signaling pathway (GO:0060337) | 2.53344009 |
| 163 | leukocyte aggregation (GO:0070486) | 2.52156945 |
| 164 | axon development (GO:0061564) | 2.52136934 |
| 165 | amyloid precursor protein metabolic process (GO:0042982) | 2.51426460 |
| 166 | regulation of B cell activation (GO:0050864) | 2.51070363 |
| 167 | positive regulation of gliogenesis (GO:0014015) | 2.50268018 |
| 168 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.50015301 |
| 169 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.50015301 |
| 170 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.49682268 |
| 171 | organ growth (GO:0035265) | 2.49077452 |
| 172 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.47705564 |
| 173 | skin morphogenesis (GO:0043589) | 2.46776412 |
| 174 | endothelial cell chemotaxis (GO:0035767) | 2.46711608 |
| 175 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.45484161 |
| 176 | cholesterol biosynthetic process (GO:0006695) | 2.43197889 |
| 177 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.42808260 |
| 178 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.41994411 |
| 179 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.40258335 |
| 180 | regulation of interleukin-13 production (GO:0032656) | 2.39662849 |
| 181 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.39043751 |
| 182 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.39043751 |
| 183 | muscle cell migration (GO:0014812) | 2.38869584 |
| 184 | genitalia morphogenesis (GO:0035112) | 2.38727203 |
| 185 | positive regulation of interleukin-4 production (GO:0032753) | 2.36129703 |
| 186 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.36037992 |
| 187 | astrocyte development (GO:0014002) | 2.35701975 |
| 188 | negative regulation of viral release from host cell (GO:1902187) | 2.35159906 |
| 189 | positive regulation of response to nutrient levels (GO:0032109) | 2.34475927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.67584278 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.78357348 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.41259719 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31919265 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95157168 |
| 6 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.84005292 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79792224 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.78525310 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.68753555 |
| 10 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.58683327 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57144695 |
| 12 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.56277357 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.48340582 |
| 14 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.37588692 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31911400 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.30236116 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.19831476 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14642526 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04869103 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03020847 |
| 21 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.02127891 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99472660 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.92807497 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87407525 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87301440 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 1.85279523 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.82492689 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.79091639 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.76970194 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76428033 |
| 31 | GATA3_26560356_Chip-Seq_TH2_Human | 1.75891620 |
| 32 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69568400 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.69388407 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.68365648 |
| 35 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59207580 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52474922 |
| 37 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.51412612 |
| 38 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.51412612 |
| 39 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49884671 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49744755 |
| 41 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.42722106 |
| 42 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42580712 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40098666 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39519869 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37978819 |
| 46 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37337109 |
| 47 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.37162805 |
| 48 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36696626 |
| 49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34500753 |
| 50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.31196239 |
| 51 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.30661595 |
| 52 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28705295 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28172425 |
| 54 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28026176 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27830185 |
| 56 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.26575913 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26575751 |
| 58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.26226992 |
| 59 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25956571 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25729887 |
| 61 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.24978269 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24503663 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23952218 |
| 64 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.23618117 |
| 65 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23158414 |
| 66 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22970549 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22429652 |
| 68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22086833 |
| 69 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.20319583 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20083806 |
| 71 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19616540 |
| 72 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.19436123 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18939910 |
| 74 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18389024 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16989479 |
| 76 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16283775 |
| 77 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.16183266 |
| 78 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.15215330 |
| 79 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15174832 |
| 80 | * MYB_26560356_Chip-Seq_TH1_Human | 1.13240789 |
| 81 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12994645 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12825427 |
| 83 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.12072400 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10454568 |
| 85 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10212199 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07568318 |
| 87 | MYC_22102868_ChIP-Seq_BL_Human | 1.07351291 |
| 88 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05311342 |
| 89 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05173020 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04960404 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04954721 |
| 92 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.04884827 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04861570 |
| 94 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04598168 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 1.03326810 |
| 96 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03034487 |
| 97 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02287130 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02287130 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01643189 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00474566 |
| 101 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.99529065 |
| 102 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99387814 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99257884 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98875586 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98875586 |
| 106 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.98145335 |
| 107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97735411 |
| 108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96796853 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96156035 |
| 110 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96003462 |
| 111 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.95966862 |
| 112 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95905126 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95763842 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95111975 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94262163 |
| 116 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.94187987 |
| 117 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93532392 |
| 118 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93264915 |
| 119 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.91800832 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91610065 |
| 121 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90511915 |
| 122 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90359685 |
| 123 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.88859775 |
| 124 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.88764645 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 0.88069422 |
| 126 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88018823 |
| 127 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.87710462 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87502211 |
| 129 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87474729 |
| 130 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.87419660 |
| 131 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87198206 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.86474349 |
| 133 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86239109 |
| 134 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.85858987 |
| 135 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85832613 |
| 136 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.84977909 |
| 137 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.84807148 |
| 138 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84426347 |
| 139 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.84426166 |
| 140 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.82874998 |
| 141 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82462184 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81524995 |
| 143 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81282690 |
| 144 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.80755488 |
| 145 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80022025 |
| 146 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79677250 |
| 147 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79587580 |
| 148 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.79348999 |
| 149 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78688900 |
| 150 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78288280 |
| 151 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77208653 |
| 152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77053838 |
| 153 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.76912784 |
| 154 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75617597 |
| 155 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.75305142 |
| 156 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.73519789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 3.93783136 |
| 2 | MP0000920_abnormal_myelination | 3.51208918 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.24712565 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.17551342 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.12676870 |
| 6 | * MP0002148_abnormal_hypersensitivity_rea | 2.95506693 |
| 7 | MP0002933_joint_inflammation | 2.83850672 |
| 8 | MP0001853_heart_inflammation | 2.78324818 |
| 9 | MP0001299_abnormal_eye_distance/ | 2.69743152 |
| 10 | MP0000003_abnormal_adipose_tissue | 2.69274746 |
| 11 | MP0009785_altered_susceptibility_to | 2.68196694 |
| 12 | MP0001348_abnormal_lacrimal_gland | 2.62466500 |
| 13 | MP0003436_decreased_susceptibility_to | 2.52290427 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.28737319 |
| 15 | MP0003195_calcinosis | 2.13240241 |
| 16 | MP0004233_abnormal_muscle_weight | 2.11789487 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.06388360 |
| 18 | MP0004270_analgesia | 2.04162900 |
| 19 | MP0000747_muscle_weakness | 2.03165990 |
| 20 | MP0002419_abnormal_innate_immunity | 1.98123558 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.95712256 |
| 22 | MP0002006_tumorigenesis | 1.95143201 |
| 23 | MP0005379_endocrine/exocrine_gland_phen | 1.89651845 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.88554219 |
| 25 | MP0009764_decreased_sensitivity_to | 1.86571582 |
| 26 | MP0000733_abnormal_muscle_development | 1.86200049 |
| 27 | MP0003303_peritoneal_inflammation | 1.85945123 |
| 28 | MP0004742_abnormal_vestibular_system | 1.84829399 |
| 29 | MP0005025_abnormal_response_to | 1.83173278 |
| 30 | MP0000749_muscle_degeneration | 1.82283716 |
| 31 | MP0000383_abnormal_hair_follicle | 1.78190986 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.76957397 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.74915022 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.72183212 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.72183212 |
| 36 | MP0002938_white_spotting | 1.71608219 |
| 37 | MP0004381_abnormal_hair_follicle | 1.71296600 |
| 38 | MP0001790_abnormal_immune_system | 1.64600734 |
| 39 | MP0005387_immune_system_phenotype | 1.64600734 |
| 40 | MP0005375_adipose_tissue_phenotype | 1.64591717 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.64464068 |
| 42 | * MP0002398_abnormal_bone_marrow | 1.59100475 |
| 43 | MP0000685_abnormal_immune_system | 1.57819299 |
| 44 | MP0009278_abnormal_bone_marrow | 1.56281476 |
| 45 | MP0002163_abnormal_gland_morphology | 1.55444518 |
| 46 | MP0001944_abnormal_pancreas_morphology | 1.54957387 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.51678732 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.51147973 |
| 49 | MP0003959_abnormal_lean_body | 1.47344066 |
| 50 | MP0003329_amyloid_beta_deposits | 1.47190589 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.47046833 |
| 52 | MP0003724_increased_susceptibility_to | 1.43607522 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.41535889 |
| 54 | MP0009840_abnormal_foam_cell | 1.41268826 |
| 55 | MP0001501_abnormal_sleep_pattern | 1.40348353 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.39973941 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.39920386 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.39352024 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.39178075 |
| 60 | MP0003828_pulmonary_edema | 1.38578650 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.38344717 |
| 62 | MP0009384_cardiac_valve_regurgitation | 1.34304104 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.33849283 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.32870807 |
| 65 | MP0008057_abnormal_DNA_replication | 1.31434223 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.31344340 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.30847626 |
| 68 | MP0010678_abnormal_skin_adnexa | 1.30413672 |
| 69 | MP0005671_abnormal_response_to | 1.30113930 |
| 70 | MP0004043_abnormal_pH_regulation | 1.29486614 |
| 71 | MP0000750_abnormal_muscle_regeneration | 1.29093698 |
| 72 | MP0002693_abnormal_pancreas_physiology | 1.28409863 |
| 73 | MP0005408_hypopigmentation | 1.25703278 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.24767853 |
| 75 | MP0002722_abnormal_immune_system | 1.24368989 |
| 76 | MP0001851_eye_inflammation | 1.23137278 |
| 77 | MP0004947_skin_inflammation | 1.20328602 |
| 78 | MP0002405_respiratory_system_inflammati | 1.18315859 |
| 79 | MP0001243_abnormal_dermal_layer | 1.17506020 |
| 80 | MP0002009_preneoplasia | 1.16722875 |
| 81 | MP0002332_abnormal_exercise_endurance | 1.16303441 |
| 82 | * MP0002429_abnormal_blood_cell | 1.15938370 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.15712670 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.15290571 |
| 85 | MP0003866_abnormal_defecation | 1.15032371 |
| 86 | * MP0005000_abnormal_immune_tolerance | 1.14328447 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.12928986 |
| 88 | MP0004134_abnormal_chest_morphology | 1.12536339 |
| 89 | MP0005410_abnormal_fertilization | 1.12178853 |
| 90 | MP0001986_abnormal_taste_sensitivity | 1.12147653 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.11933518 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 1.11404114 |
| 93 | MP0008469_abnormal_protein_level | 1.10541088 |
| 94 | MP0001485_abnormal_pinna_reflex | 1.10190260 |
| 95 | MP0000613_abnormal_salivary_gland | 1.10040569 |
| 96 | MP0002166_altered_tumor_susceptibility | 1.09952012 |
| 97 | MP0001340_abnormal_eyelid_morphology | 1.09633868 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 1.09328614 |
| 99 | MP0000428_abnormal_craniofacial_morphol | 1.08551797 |
| 100 | MP0004087_abnormal_muscle_fiber | 1.07957774 |
| 101 | MP0001873_stomach_inflammation | 1.07578364 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 1.07569507 |
| 103 | MP0003045_fibrosis | 1.06918604 |
| 104 | MP0003634_abnormal_glial_cell | 1.06705716 |
| 105 | MP0002168_other_aberrant_phenotype | 1.05888759 |
| 106 | MP0003252_abnormal_bile_duct | 1.05508734 |
| 107 | MP0009763_increased_sensitivity_to | 1.03463003 |
| 108 | MP0002177_abnormal_outer_ear | 1.03440995 |
| 109 | MP0002106_abnormal_muscle_physiology | 1.01339127 |
| 110 | MP0005310_abnormal_salivary_gland | 0.99955533 |
| 111 | MP0001529_abnormal_vocalization | 0.99397534 |
| 112 | MP0005670_abnormal_white_adipose | 0.99127861 |
| 113 | MP0006054_spinal_hemorrhage | 0.97203077 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.96933107 |
| 115 | MP0003786_premature_aging | 0.96894947 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.94560334 |
| 117 | * MP0002723_abnormal_immune_serum | 0.94104147 |
| 118 | MP0005369_muscle_phenotype | 0.94101952 |
| 119 | MP0001800_abnormal_humoral_immune | 0.92284147 |
| 120 | MP0002751_abnormal_autonomic_nervous | 0.92094460 |
| 121 | MP0008438_abnormal_cutaneous_collagen | 0.91903900 |
| 122 | MP0006082_CNS_inflammation | 0.91416660 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.90809511 |
| 124 | MP0005645_abnormal_hypothalamus_physiol | 0.90497786 |
| 125 | MP0009250_abnormal_appendicular_skeleto | 0.90316155 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.90219614 |
| 127 | MP0005164_abnormal_response_to | 0.89815021 |
| 128 | MP0008995_early_reproductive_senescence | 0.89017306 |
| 129 | MP0003091_abnormal_cell_migration | 0.88163276 |
| 130 | MP0000462_abnormal_digestive_system | 0.88037690 |
| 131 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87843395 |
| 132 | MP0003300_gastrointestinal_ulcer | 0.87236563 |
| 133 | MP0002971_abnormal_brown_adipose | 0.86213461 |
| 134 | MP0002269_muscular_atrophy | 0.85104636 |
| 135 | MP0002108_abnormal_muscle_morphology | 0.84832431 |
| 136 | MP0005174_abnormal_tail_pigmentation | 0.83738703 |
| 137 | MP0003448_altered_tumor_morphology | 0.83490663 |
| 138 | MP0010030_abnormal_orbit_morphology | 0.83426018 |
| 139 | MP0005508_abnormal_skeleton_morphology | 0.81811128 |
| 140 | MP0003943_abnormal_hepatobiliary_system | 0.81642672 |
| 141 | * MP0002420_abnormal_adaptive_immunity | 0.81413485 |
| 142 | MP0001533_abnormal_skeleton_physiology | 0.80186017 |
| 143 | MP0003795_abnormal_bone_structure | 0.79855857 |
| 144 | MP0005647_abnormal_sex_gland | 0.79661585 |
| 145 | MP0001727_abnormal_embryo_implantation | 0.79510767 |
| 146 | MP0000858_altered_metastatic_potential | 0.79409544 |
| 147 | MP0008007_abnormal_cellular_replicative | 0.79015287 |
| 148 | MP0001661_extended_life_span | 0.78189427 |
| 149 | * MP0001819_abnormal_immune_cell | 0.76760785 |
| 150 | MP0003172_abnormal_lysosome_physiology | 0.76094994 |
| 151 | MP0005165_increased_susceptibility_to | 0.74985137 |
| 152 | MP0001502_abnormal_circadian_rhythm | 0.74570949 |
| 153 | MP0008961_abnormal_basal_metabolism | 0.74393194 |
| 154 | * MP0000716_abnormal_immune_system | 0.74021740 |
| 155 | MP0001542_abnormal_bone_strength | 0.73863605 |
| 156 | MP0005666_abnormal_adipose_tissue | 0.73710504 |
| 157 | MP0000371_diluted_coat_color | 0.73226524 |
| 158 | MP0000343_altered_response_to | 0.72901508 |
| 159 | MP0005390_skeleton_phenotype | 0.71377402 |
| 160 | MP0002254_reproductive_system_inflammat | 0.71017209 |
| 161 | MP0002019_abnormal_tumor_incidence | 0.70923846 |
| 162 | MP0000465_gastrointestinal_hemorrhage | 0.70725110 |
| 163 | MP0005166_decreased_susceptibility_to | 0.69691666 |
| 164 | MP0001764_abnormal_homeostasis | 0.68550450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune hemolytic anemia (HP:0001890) | 4.90017465 |
| 2 | Muscle fiber splitting (HP:0003555) | 4.39661899 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12366330 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.00167101 |
| 5 | Albinism (HP:0001022) | 3.88866756 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 3.88250143 |
| 7 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.87812578 |
| 8 | Abnormality of the prostate (HP:0008775) | 3.85169534 |
| 9 | Fatigue (HP:0012378) | 3.82361684 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.75745028 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.73689484 |
| 12 | T lymphocytopenia (HP:0005403) | 3.65937741 |
| 13 | Anteriorly placed anus (HP:0001545) | 3.63630362 |
| 14 | Peripheral hypomyelination (HP:0007182) | 3.56352152 |
| 15 | Spondylolisthesis (HP:0003302) | 3.54381113 |
| 16 | Nemaline bodies (HP:0003798) | 3.49706399 |
| 17 | Hyperglycemia (HP:0003074) | 3.48760660 |
| 18 | Prostate neoplasm (HP:0100787) | 3.48500014 |
| 19 | Stomach cancer (HP:0012126) | 3.48333253 |
| 20 | Pulmonary infiltrates (HP:0002113) | 3.43146792 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.40672530 |
| 22 | Metaphyseal dysplasia (HP:0100255) | 3.34470743 |
| 23 | Chronic diarrhea (HP:0002028) | 3.32605122 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.27510280 |
| 25 | Cerebral hypomyelination (HP:0006808) | 3.27456625 |
| 26 | Sensory axonal neuropathy (HP:0003390) | 3.21213754 |
| 27 | Parakeratosis (HP:0001036) | 3.17110420 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.11960929 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.11960929 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.11960929 |
| 31 | Premature rupture of membranes (HP:0001788) | 3.07417790 |
| 32 | White forelock (HP:0002211) | 3.04651391 |
| 33 | Gowers sign (HP:0003391) | 3.03313309 |
| 34 | Onion bulb formation (HP:0003383) | 2.97690188 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.96314730 |
| 36 | Upper limb muscle weakness (HP:0003484) | 2.93256974 |
| 37 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.93121720 |
| 38 | Recurrent viral infections (HP:0004429) | 2.91366996 |
| 39 | Alveolar cell carcinoma (HP:0006519) | 2.89568783 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 2.88988293 |
| 41 | Pheochromocytoma (HP:0002666) | 2.87025446 |
| 42 | IgG deficiency (HP:0004315) | 2.86830889 |
| 43 | Vacuolated lymphocytes (HP:0001922) | 2.85945425 |
| 44 | Vasculitis (HP:0002633) | 2.85848954 |
| 45 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.85047107 |
| 46 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.85047107 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.84530847 |
| 48 | Stomatitis (HP:0010280) | 2.80756496 |
| 49 | Retrobulbar optic neuritis (HP:0100654) | 2.80445987 |
| 50 | Optic neuritis (HP:0100653) | 2.80445987 |
| 51 | Myositis (HP:0100614) | 2.78188783 |
| 52 | Alacrima (HP:0000522) | 2.77981889 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.77965252 |
| 54 | Weak cry (HP:0001612) | 2.77781178 |
| 55 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.77599782 |
| 56 | Severe combined immunodeficiency (HP:0004430) | 2.73814068 |
| 57 | Round ear (HP:0100830) | 2.72378028 |
| 58 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.63786257 |
| 59 | Atonic seizures (HP:0010819) | 2.58698223 |
| 60 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.55700025 |
| 61 | Hypoplastic ischia (HP:0003175) | 2.54695612 |
| 62 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.54231001 |
| 63 | Follicular hyperkeratosis (HP:0007502) | 2.52883665 |
| 64 | Panhypogammaglobulinemia (HP:0003139) | 2.52186228 |
| 65 | Patchy hypopigmentation of hair (HP:0011365) | 2.51392043 |
| 66 | Stridor (HP:0010307) | 2.50510459 |
| 67 | Neuroendocrine neoplasm (HP:0100634) | 2.48856705 |
| 68 | Meningitis (HP:0001287) | 2.47184819 |
| 69 | Abnormality of male internal genitalia (HP:0000022) | 2.46385588 |
| 70 | Type 2 muscle fiber atrophy (HP:0003554) | 2.45115717 |
| 71 | Depressed nasal tip (HP:0000437) | 2.44304092 |
| 72 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.42302005 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.42266306 |
| 74 | Premature skin wrinkling (HP:0100678) | 2.41274916 |
| 75 | Orchitis (HP:0100796) | 2.40969650 |
| 76 | Pulmonary fibrosis (HP:0002206) | 2.38855115 |
| 77 | Granulocytopenia (HP:0001913) | 2.38638315 |
| 78 | Difficulty running (HP:0009046) | 2.36465530 |
| 79 | Acute myeloid leukemia (HP:0004808) | 2.34810445 |
| 80 | Abnormality of the neuromuscular junction (HP:0003398) | 2.32538415 |
| 81 | Fatigable weakness (HP:0003473) | 2.32538415 |
| 82 | EMG: myopathic abnormalities (HP:0003458) | 2.32314062 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31427113 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31427113 |
| 85 | Large for gestational age (HP:0001520) | 2.30621529 |
| 86 | Increased IgM level (HP:0003496) | 2.29319364 |
| 87 | Alopecia of scalp (HP:0002293) | 2.29009933 |
| 88 | Hypoplastic pelvis (HP:0008839) | 2.28969389 |
| 89 | Recurrent bronchitis (HP:0002837) | 2.25122104 |
| 90 | Nonprogressive disorder (HP:0003680) | 2.24674479 |
| 91 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.22442553 |
| 92 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.22442553 |
| 93 | Hypoglycemic seizures (HP:0002173) | 2.21977452 |
| 94 | Xerostomia (HP:0000217) | 2.21691686 |
| 95 | Decreased lacrimation (HP:0000633) | 2.20104649 |
| 96 | Exercise-induced myalgia (HP:0003738) | 2.18797891 |
| 97 | Exocrine pancreatic insufficiency (HP:0001738) | 2.17964700 |
| 98 | Abnormal hair whorl (HP:0010721) | 2.16978113 |
| 99 | Combined immunodeficiency (HP:0005387) | 2.16795458 |
| 100 | Neck muscle weakness (HP:0000467) | 2.15704529 |
| 101 | Petechiae (HP:0000967) | 2.15550740 |
| 102 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.10982372 |
| 103 | Generalized hypopigmentation (HP:0007513) | 2.09195168 |
| 104 | Gangrene (HP:0100758) | 2.08387605 |
| 105 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.07733886 |
| 106 | Abnormality of dental color (HP:0011073) | 2.06985443 |
| 107 | Epiphyseal dysplasia (HP:0002656) | 2.06475113 |
| 108 | Joint swelling (HP:0001386) | 2.06474820 |
| 109 | Ectropion (HP:0000656) | 2.06349982 |
| 110 | Muscle fiber atrophy (HP:0100295) | 2.06110418 |
| 111 | Cone-rod dystrophy (HP:0000548) | 2.05837773 |
| 112 | Abnormality of the labia majora (HP:0012881) | 2.05509681 |
| 113 | Menstrual irregularities (HP:0000858) | 2.05423030 |
| 114 | Akinesia (HP:0002304) | 2.04796389 |
| 115 | Toxemia of pregnancy (HP:0100603) | 2.04492324 |
| 116 | Glucose intolerance (HP:0000833) | 2.03668814 |
| 117 | Thickened helices (HP:0000391) | 2.03407099 |
| 118 | Abnormality of the ischium (HP:0003174) | 2.00824080 |
| 119 | Hypoplastic labia majora (HP:0000059) | 2.00581562 |
| 120 | Submucous cleft hard palate (HP:0000176) | 2.00449091 |
| 121 | Broad face (HP:0000283) | 1.99207483 |
| 122 | Erythema (HP:0010783) | 1.97265397 |
| 123 | Hemoptysis (HP:0002105) | 1.97045564 |
| 124 | Type 1 muscle fiber predominance (HP:0003803) | 1.97008271 |
| 125 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95558214 |
| 126 | Easy fatigability (HP:0003388) | 1.95515549 |
| 127 | Keratitis (HP:0000491) | 1.95109393 |
| 128 | Scapular winging (HP:0003691) | 1.94936968 |
| 129 | IgA deficiency (HP:0002720) | 1.94818761 |
| 130 | Recurrent bacterial skin infections (HP:0005406) | 1.94715589 |
| 131 | Eosinophilia (HP:0001880) | 1.92771570 |
| 132 | Progressive neurologic deterioration (HP:0002344) | 1.91222703 |
| 133 | Loss of speech (HP:0002371) | 1.91182163 |
| 134 | Abnormality of the calf musculature (HP:0001430) | 1.90910329 |
| 135 | Leukocytosis (HP:0001974) | 1.90792069 |
| 136 | Hyperkalemia (HP:0002153) | 1.90430827 |
| 137 | Calf muscle hypertrophy (HP:0008981) | 1.90387355 |
| 138 | Encephalitis (HP:0002383) | 1.89688103 |
| 139 | Chronic otitis media (HP:0000389) | 1.89617655 |
| 140 | Abnormality of macrophages (HP:0004311) | 1.88449880 |
| 141 | Abnormality of eosinophils (HP:0001879) | 1.87764259 |
| 142 | Recurrent abscess formation (HP:0002722) | 1.87062222 |
| 143 | Symptomatic seizures (HP:0011145) | 1.86502871 |
| 144 | Gastrointestinal stroma tumor (HP:0100723) | 1.85847323 |
| 145 | Acute lymphatic leukemia (HP:0006721) | 1.84617878 |
| 146 | Abnormality of T cells (HP:0002843) | 1.84329499 |
| 147 | Keratoconjunctivitis sicca (HP:0001097) | 1.83644637 |
| 148 | Thyroiditis (HP:0100646) | 1.83385646 |
| 149 | Flat capital femoral epiphysis (HP:0003370) | 1.83379127 |
| 150 | Slow saccadic eye movements (HP:0000514) | 1.81739451 |
| 151 | CNS hypomyelination (HP:0003429) | 1.81364803 |
| 152 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81160806 |
| 153 | Viral hepatitis (HP:0006562) | 1.79913215 |
| 154 | Osteomyelitis (HP:0002754) | 1.79032752 |
| 155 | Popliteal pterygium (HP:0009756) | 1.78508020 |
| 156 | Arterial thrombosis (HP:0004420) | 1.78359666 |
| 157 | Lymphopenia (HP:0001888) | 1.78238385 |
| 158 | Hypoplastic iliac wings (HP:0002866) | 1.77496778 |
| 159 | Hypoproteinemia (HP:0003075) | 1.77169357 |
| 160 | Increased density of long bones (HP:0006392) | 1.76661945 |
| 161 | Pustule (HP:0200039) | 1.76414779 |
| 162 | Glomerulopathy (HP:0100820) | 1.75289262 |
| 163 | Infantile muscular hypotonia (HP:0008947) | 1.74803995 |
| 164 | Keratoconjunctivitis (HP:0001096) | 1.73960610 |
| 165 | Myocardial infarction (HP:0001658) | 1.73954727 |
| 166 | Barrel-shaped chest (HP:0001552) | 1.73848966 |
| 167 | Adrenal hypoplasia (HP:0000835) | 1.73167325 |
| 168 | Split foot (HP:0001839) | 1.72796057 |
| 169 | Foot dorsiflexor weakness (HP:0009027) | 1.72709991 |
| 170 | Recurrent skin infections (HP:0001581) | 1.72242740 |
| 171 | B lymphocytopenia (HP:0010976) | 1.71769007 |
| 172 | Abnormality of B cell number (HP:0010975) | 1.71769007 |
| 173 | Chest pain (HP:0100749) | 1.71639875 |
| 174 | Irregular vertebral endplates (HP:0003301) | 1.71596191 |
| 175 | Dysostosis multiplex (HP:0000943) | 1.71391528 |
| 176 | Mask-like facies (HP:0000298) | 1.71175496 |
| 177 | Anhidrosis (HP:0000970) | 1.70660461 |
| 178 | Agitation (HP:0000713) | 1.68757508 |
| 179 | Autoamputation (HP:0001218) | 1.68342332 |
| 180 | Febrile seizures (HP:0002373) | 1.68301744 |
| 181 | Abnormality of the pleura (HP:0002103) | 1.67869469 |
| 182 | Amniotic constriction ring (HP:0009775) | 1.67564983 |
| 183 | Abnormality of placental membranes (HP:0011409) | 1.67564983 |
| 184 | Gaze-evoked nystagmus (HP:0000640) | 1.67476716 |
| 185 | Increased CSF protein (HP:0002922) | 1.67030062 |
| 186 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.67011809 |
| 187 | Myopathic facies (HP:0002058) | 1.66828391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 4.38605420 |
| 2 | EIF2AK3 | 4.30251846 |
| 3 | MAPK15 | 4.22470379 |
| 4 | WNK3 | 3.86847401 |
| 5 | BRSK2 | 3.56016746 |
| 6 | EPHB1 | 3.51068921 |
| 7 | TXK | 3.08661833 |
| 8 | STK39 | 3.01904612 |
| 9 | TRIM28 | 2.79198837 |
| 10 | MAP4K1 | 2.56160319 |
| 11 | WNK4 | 2.55030927 |
| 12 | NLK | 2.26643111 |
| 13 | BMPR2 | 2.26033291 |
| 14 | TESK2 | 2.24195201 |
| 15 | EPHA3 | 2.20104749 |
| 16 | OXSR1 | 2.14764580 |
| 17 | ITK | 2.11649720 |
| 18 | ERBB3 | 2.08739586 |
| 19 | FGFR4 | 2.03299153 |
| 20 | MUSK | 2.00921087 |
| 21 | BMPR1B | 1.91869678 |
| 22 | LIMK1 | 1.83841854 |
| 23 | WEE1 | 1.78871372 |
| 24 | PKN1 | 1.78175407 |
| 25 | HIPK2 | 1.77288222 |
| 26 | WNK1 | 1.69882734 |
| 27 | MAP3K12 | 1.65985227 |
| 28 | RPS6KA5 | 1.53611158 |
| 29 | KIT | 1.50337771 |
| 30 | MST4 | 1.45038633 |
| 31 | PAK3 | 1.42624876 |
| 32 | MAPKAPK5 | 1.38315863 |
| 33 | UHMK1 | 1.36617951 |
| 34 | CSNK1A1L | 1.35355048 |
| 35 | FLT3 | 1.32238511 |
| 36 | CDK19 | 1.31468804 |
| 37 | STK10 | 1.30770970 |
| 38 | GRK7 | 1.27552272 |
| 39 | CSNK1G3 | 1.27494667 |
| 40 | DMPK | 1.26914414 |
| 41 | MARK2 | 1.25746808 |
| 42 | CSNK1G1 | 1.23874797 |
| 43 | BCR | 1.22284451 |
| 44 | MKNK2 | 1.21139560 |
| 45 | FRK | 1.20842754 |
| 46 | FGFR2 | 1.18959436 |
| 47 | NEK6 | 1.12489971 |
| 48 | PIK3CG | 1.11715361 |
| 49 | EPHA2 | 1.09651442 |
| 50 | PRKD2 | 1.09371219 |
| 51 | TRPM7 | 1.08200096 |
| 52 | BRD4 | 1.08186681 |
| 53 | ADRBK2 | 1.05628942 |
| 54 | STK24 | 1.05451622 |
| 55 | CSK | 1.04665035 |
| 56 | IRAK3 | 1.03828623 |
| 57 | IRAK1 | 1.00822654 |
| 58 | PRKCQ | 1.00794537 |
| 59 | PRKCH | 0.97396620 |
| 60 | TTN | 0.95849887 |
| 61 | EIF2AK2 | 0.95666896 |
| 62 | PRPF4B | 0.94241999 |
| 63 | CAMK2D | 0.93812474 |
| 64 | IRAK4 | 0.92014077 |
| 65 | MET | 0.91809075 |
| 66 | CAMK2B | 0.90623753 |
| 67 | MAP3K14 | 0.89375314 |
| 68 | BTK | 0.87608801 |
| 69 | MOS | 0.87371024 |
| 70 | CLK1 | 0.87203647 |
| 71 | TSSK6 | 0.86867627 |
| 72 | AKT3 | 0.86127128 |
| 73 | MAP2K2 | 0.85505457 |
| 74 | GRK1 | 0.83988625 |
| 75 | OBSCN | 0.83984938 |
| 76 | PDGFRB | 0.82134312 |
| 77 | BRSK1 | 0.79962269 |
| 78 | DYRK1B | 0.79274944 |
| 79 | ERBB4 | 0.78738055 |
| 80 | MAPK7 | 0.77998488 |
| 81 | LCK | 0.77663345 |
| 82 | CSF1R | 0.77137444 |
| 83 | PRKCI | 0.75029650 |
| 84 | MARK3 | 0.74511439 |
| 85 | STK38L | 0.74014743 |
| 86 | MAPK11 | 0.73702533 |
| 87 | ROCK2 | 0.73200159 |
| 88 | PDK2 | 0.72944237 |
| 89 | CSNK1G2 | 0.72532446 |
| 90 | SIK1 | 0.72402514 |
| 91 | MELK | 0.71655446 |
| 92 | CAMK2G | 0.71017901 |
| 93 | TYK2 | 0.70938945 |
| 94 | NME1 | 0.70713221 |
| 95 | MAPKAPK3 | 0.67187912 |
| 96 | ZAP70 | 0.65688929 |
| 97 | IKBKE | 0.65246856 |
| 98 | STK3 | 0.65236189 |
| 99 | ICK | 0.63985887 |
| 100 | TGFBR2 | 0.63644074 |
| 101 | SYK | 0.62869362 |
| 102 | CHUK | 0.61897854 |
| 103 | JAK3 | 0.61861476 |
| 104 | PRKD1 | 0.61618708 |
| 105 | MAP3K13 | 0.60483453 |
| 106 | PIM2 | 0.59485945 |
| 107 | ABL1 | 0.59296945 |
| 108 | MKNK1 | 0.57912734 |
| 109 | FER | 0.54936716 |
| 110 | PIM1 | 0.54699926 |
| 111 | GSK3A | 0.53263438 |
| 112 | TAOK3 | 0.53188321 |
| 113 | DYRK2 | 0.50700655 |
| 114 | NUAK1 | 0.50482071 |
| 115 | CDK8 | 0.49620820 |
| 116 | TBK1 | 0.49486575 |
| 117 | MATK | 0.46602945 |
| 118 | CCNB1 | 0.46031790 |
| 119 | MAPKAPK2 | 0.45858763 |
| 120 | MAP3K1 | 0.45754642 |
| 121 | INSR | 0.44726435 |
| 122 | PTK2 | 0.44694252 |
| 123 | HCK | 0.44541154 |
| 124 | DDR2 | 0.42658058 |
| 125 | PAK6 | 0.42515023 |
| 126 | PBK | 0.41345816 |
| 127 | PLK2 | 0.40991561 |
| 128 | TESK1 | 0.40540946 |
| 129 | IGF1R | 0.40009731 |
| 130 | STK16 | 0.39581995 |
| 131 | RIPK4 | 0.39122979 |
| 132 | MAP3K5 | 0.38772307 |
| 133 | SGK223 | 0.37799158 |
| 134 | SGK494 | 0.37799158 |
| 135 | MAP3K7 | 0.37780078 |
| 136 | RPS6KA4 | 0.37710826 |
| 137 | TEC | 0.35799098 |
| 138 | IKBKB | 0.35681992 |
| 139 | MAP3K10 | 0.34996687 |
| 140 | PDPK1 | 0.34148423 |
| 141 | TAOK2 | 0.33423919 |
| 142 | LYN | 0.33142588 |
| 143 | CDK3 | 0.31547514 |
| 144 | MAPK4 | 0.31232661 |
| 145 | ARAF | 0.30961998 |
| 146 | MAP3K3 | 0.30105466 |
| 147 | MAPK8 | 0.30010649 |
| 148 | JAK1 | 0.29492917 |
| 149 | EGFR | 0.28623390 |
| 150 | MAPK3 | 0.28190671 |
| 151 | PRKCE | 0.27626281 |
| 152 | VRK1 | 0.27511034 |
| 153 | PIK3CA | 0.27105929 |
| 154 | ABL2 | 0.26962150 |
| 155 | MYLK | 0.26246178 |
| 156 | FES | 0.23895509 |
| 157 | NEK9 | 0.22146884 |
| 158 | CDK6 | 0.20774465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.61327267 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.20586251 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.13831797 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.04670190 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.87841647 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.66597481 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.56641885 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10044620 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.07348435 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05309897 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.04970969 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.01289473 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89293333 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87885051 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.87756917 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.76493723 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.76261360 |
| 18 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.73714419 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.72582067 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.70485328 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68240012 |
| 22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.64553502 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64498368 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.59871830 |
| 25 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.59255879 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57942949 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.56078754 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.55990901 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40600577 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37637227 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.34328193 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.33329298 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26504968 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26149203 |
| 35 | Proteasome_Homo sapiens_hsa03050 | 1.23157879 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21435708 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20389048 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20049000 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.19803544 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.18494074 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16488601 |
| 42 | Endocytosis_Homo sapiens_hsa04144 | 1.15254014 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12312372 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.11959860 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11726666 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11374423 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10239769 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10234014 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08134577 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07792658 |
| 51 | Prostate cancer_Homo sapiens_hsa05215 | 1.06543912 |
| 52 | Measles_Homo sapiens_hsa05162 | 1.02735289 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01454918 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00450202 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99257386 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97617876 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95933587 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94865602 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.94466892 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.94117898 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.91940492 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.91635019 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 0.88020970 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87736387 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.87073188 |
| 66 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86402045 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86070263 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.84562808 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84039604 |
| 70 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82319575 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.80739859 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77948086 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77014914 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75056840 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.75028490 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74896048 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74712212 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.74152043 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72515051 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.72452309 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72335394 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72161731 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72070064 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71013752 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.70388214 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70085273 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.69624832 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69487234 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69367744 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68991914 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68765731 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68503981 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68316034 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.67767338 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67203725 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67126431 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65599939 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64897879 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64596608 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64204160 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63882618 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62144294 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61764699 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61748128 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61319823 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60921645 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59511359 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59306140 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57630576 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57263731 |
| 111 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56121593 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.55091303 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54269924 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53944639 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53750992 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51554604 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50943436 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50598838 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50554924 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49625201 |
| 121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.48284339 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.47738552 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47557027 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47319366 |
| 125 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47189246 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46470396 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45536497 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44572745 |
| 129 | Long-term depression_Homo sapiens_hsa04730 | 0.44375392 |
| 130 | Apoptosis_Homo sapiens_hsa04210 | 0.44068247 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42398490 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41655136 |
| 133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38043457 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37744594 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37164250 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.36221978 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35092744 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.34167583 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30853605 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30147346 |
| 141 | Phototransduction_Homo sapiens_hsa04744 | 0.29618924 |
| 142 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25328595 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | 0.25083341 |
| 144 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20609678 |
| 145 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.18284628 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16783077 |
| 147 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15864910 |

